• AMPLIRUN® SARS-CoV-2 PANEL
    Amplification Controls

    B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma)
    and B.1.617.2 (Delta) variants, now available


  • VirClia®, the True Monotest
    for COVID-19 Diagnosis

    COVID-19 VIRCLIA IgM+IgA MONOTEST
    COVID-19 VIRCLIA IgG MONOTEST


  • New SARS-CoV-2 VARIANTS RealTime PCR kit

    Detection and identification of the main variants of concern in a single reaction tube


  • ELISA Solution
    for COVID-19 Diagnosis

    COVID-19 ELISA IgM+IgA · COVID-19 ELISA IgG


  • SARS-COV-2
    Picture from Vircell culture collection


Two approaches, one mission

Development and production of diagnostic reagents for human infectious diseases

ico-microviologist.png

Vircell Microbiologists

Ready-to-use kits under serological methods for the diagnosis of human infectious diseases.

adn-new.png

Vircell Molecular

Real time PCR kits and independent molecular controls for a wide range of infectious diseases.

VIRCLIA ® LOTUS

This fully automated random access and continuous loading CLIA analyser allows to run more than 95 infectious markers in a monotest format with total flexibility and no need of reagents on board.
VirClia® Lotus brings a revolution to the infectious serology labs as it enables to perform in just one CLIA system low-volume parameters daily, alongside the laboratory routine.

More information

Development and production of diagnostic reagents for human infectious diseases

Biotechnology Company

Vircell, S.L is a biotechnology company specialized in the development and production of ready to use reagents for human infectious diseases. We are present in laboratories of more than 90 countries worldwide on five continents. Vircell, S.L. offers more than 500 references for the detection of bacteria, viruses, parasites and fungi by means of different techniques: ELISA, chemiluminescence, direct and indirect immunofluorescence, immunocapture agglutination, cell culture and Molecular Biology (Real Time PCR and PCR controls).

More information

Latest News

News and Events

30 November 2021 Omicron variant The new SARS-CoV-2 Omicron variant, identified for the first time November 26th, 2021, has been ...
22 November 2021 MEDICA 2021 MEDICA constitutes one of the most important meeting points of the year in the medical ...
Show all news
24 January 2022 MEDLAB Middle East 2022 Vircell will attend one of the most important events in the IVD sector in the ...
02 February 2022 10th Advances Against Aspergillosis and Mucormycosis We are glad to announce that Vircell will be participating in the virtual 10th conference ...
See all events

Newsletter

Receive all our news in your email